ATE3239T1 - Verfahren zum isolieren viraler glycoproteinischer antigene und deren verwendung fuer die bereitung von impfstoffen. - Google Patents

Verfahren zum isolieren viraler glycoproteinischer antigene und deren verwendung fuer die bereitung von impfstoffen.

Info

Publication number
ATE3239T1
ATE3239T1 AT81400815T AT81400815T ATE3239T1 AT E3239 T1 ATE3239 T1 AT E3239T1 AT 81400815 T AT81400815 T AT 81400815T AT 81400815 T AT81400815 T AT 81400815T AT E3239 T1 ATE3239 T1 AT E3239T1
Authority
AT
Austria
Prior art keywords
vaccines
preparation
viral glycoprotein
glycoprotein antigens
isolating viral
Prior art date
Application number
AT81400815T
Other languages
English (en)
Inventor
Jean Leclerc
Jean De Rudder
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE3239T1 publication Critical patent/ATE3239T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT81400815T 1980-06-05 1981-05-22 Verfahren zum isolieren viraler glycoproteinischer antigene und deren verwendung fuer die bereitung von impfstoffen. ATE3239T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8012522A FR2483779A1 (fr) 1980-06-05 1980-06-05 Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins
EP81400815A EP0041880B1 (de) 1980-06-05 1981-05-22 Verfahren zum Isolieren viraler Glycoproteinischer Antigene und deren Verwendung für die Bereitung von Impfstoffen

Publications (1)

Publication Number Publication Date
ATE3239T1 true ATE3239T1 (de) 1983-05-15

Family

ID=9242745

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81400815T ATE3239T1 (de) 1980-06-05 1981-05-22 Verfahren zum isolieren viraler glycoproteinischer antigene und deren verwendung fuer die bereitung von impfstoffen.

Country Status (19)

Country Link
US (1) US4344935A (de)
EP (1) EP0041880B1 (de)
JP (1) JPS5726624A (de)
AR (1) AR228865A1 (de)
AT (1) ATE3239T1 (de)
AU (1) AU546088B2 (de)
CA (1) CA1174598A (de)
DE (1) DE3160264D1 (de)
DK (1) DK228081A (de)
ES (1) ES8203225A1 (de)
FI (1) FI811685L (de)
FR (1) FR2483779A1 (de)
GR (1) GR74610B (de)
IE (1) IE51226B1 (de)
IL (1) IL62913A (de)
NO (1) NO811873L (de)
NZ (1) NZ197306A (de)
PT (1) PT73032B (de)
ZA (1) ZA813479B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721675A (en) * 1982-02-01 1988-01-26 Abbott Laboratories Production of hepatitis A virus in vitro utilizing a persistently virus infected cell culture system
US4645666A (en) * 1982-06-08 1987-02-24 The Regents Of The University Of California Vaccine for bluetongue disease employing platinum compounds
GB8502096D0 (en) * 1985-01-28 1985-02-27 Medical Res Council Influenza vaccine
NZ224422A (en) 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US4909940A (en) * 1987-12-30 1990-03-20 New York Blood Center, Inc. Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons
US4975119A (en) * 1989-04-25 1990-12-04 Rheox, Inc. Liquid antisettling agents for organic coating compositions
FR2671974A1 (fr) * 1991-01-24 1992-07-31 Pasteur Merieux Serums Vacc Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
US5741493A (en) * 1991-01-24 1998-04-21 Pasteur Merieux Serums Et Vaccins Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
US6780630B1 (en) * 1992-07-10 2004-08-24 Baylor College Of Medicine Parenteral immunization against rotavirus
FR2723740B1 (fr) * 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
DE69629812T2 (de) 1995-06-14 2004-04-01 Baylor College Of Medicine, Houston Impfstoff gegen rotavirus infektionen enthaltend peptide des viralenterotoxines nsp4
US6673355B1 (en) 1995-06-14 2004-01-06 Baylor College Of Medicine Rotavirus enterotoxin NSP4 and methods of using same
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE661402A (de) 1964-03-20
US3847737A (en) * 1965-03-22 1974-11-12 A Kanarek Inactivation of myxoviruses and method of preparing a vaccine therefrom
US3629470A (en) * 1968-04-08 1971-12-21 Burroughs Wellcome Co Process for purification of animal rna viruses
BR6915288D0 (pt) * 1969-03-15 1973-02-08 Bayer Ag Processo para a purificacao de solucoes do virus da febre aftosa
US3989818A (en) * 1970-08-14 1976-11-02 South African Inventions Development Corporation Influenza virus vaccine
US3790552A (en) * 1972-03-16 1974-02-05 Us Health Method of removing hepatitis-associated antigen from a protein fraction using polyethylene glycol
US3962421A (en) * 1973-06-18 1976-06-08 American Home Products Corporation Method for the disruption of lipid-containing viruses
GB1486557A (en) 1973-10-18 1977-09-21 Flockhart & Co Process for the preparation of pyrogen-free sub-unit vaccine
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4064232A (en) * 1974-01-14 1977-12-20 Sandoz Ltd. Process for isolating the immunogenic components of influenza viruses
US4140762A (en) * 1974-01-14 1979-02-20 Sandoz Ltd. Influenza sub-unit vaccine
AU507149B2 (en) 1975-01-16 1980-02-07 Mount Sinai School Of Medicine Of The City University Of New York, The Method of influenza immunization
FR2422720A2 (fr) 1977-04-26 1979-11-09 Elf Aquitaine Separation et purification de proteines par chromatographie
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
DE2750045A1 (de) * 1977-11-09 1979-05-10 Behringwerke Ag Verfahren zur entfernung von detergentien aus virusantigensuspensionen

Also Published As

Publication number Publication date
PT73032B (fr) 1982-07-01
EP0041880A1 (de) 1981-12-16
AU546088B2 (en) 1985-08-15
IE811168L (en) 1981-12-05
IL62913A0 (en) 1981-07-31
PT73032A (fr) 1981-06-01
EP0041880B1 (de) 1983-05-11
FI811685L (fi) 1981-12-06
FR2483779A1 (fr) 1981-12-11
DK228081A (da) 1981-12-06
DE3160264D1 (en) 1983-06-16
GR74610B (de) 1984-06-29
AR228865A1 (es) 1983-04-29
CA1174598A (en) 1984-09-18
JPS5726624A (en) 1982-02-12
AU7117081A (en) 1981-12-10
US4344935A (en) 1982-08-17
NO811873L (no) 1981-12-07
ES502549A0 (es) 1982-04-01
NZ197306A (en) 1984-03-16
ES8203225A1 (es) 1982-04-01
IL62913A (en) 1984-08-31
IE51226B1 (en) 1986-11-12
FR2483779B1 (de) 1983-07-22
ZA813479B (en) 1982-06-30

Similar Documents

Publication Publication Date Title
DE3381761D1 (de) Material und verfahren fuer herpes simplex virusimpfung.
GB2102810B (en) Human interferon-related peptides antigens antibodies and process for preparing the same
IL78472A0 (en) Hepatitis b surface antigen formed by recombinant dna techniques,vaccines,diagnostics,cell lines and methods of forming same
DE3768833D1 (de) Verfahren zur herstellung von hcmv-glykoproteinen, antikoerper dagegen und hcmv-vakzine und dazu zu verwendende rekombinante vektoren.
PT86640A (pt) Hepatitis b virus surface antigens and hybrid antigens containing them
EP0126450A3 (en) Particle and method for the detection of antigens and/or antibodies using this particle
DE3485723D1 (de) Verfahren und signalsequenz fuer die extrazellulare herstellung von proteinmaterial.
ATE3239T1 (de) Verfahren zum isolieren viraler glycoproteinischer antigene und deren verwendung fuer die bereitung von impfstoffen.
IL70947A (en) Synthetic polypeptides from viral oncogenes,antigens,diagnostic reagents and vaccines including them,and method for using same for detecting diseases
IL73428A0 (en) Anti-idiotype antibodies against a tumor or virus,method and cell lines for producing them and compositions containing them
ZA826310B (en) Products displaying the antigenicity of hepatitis b virus e antigens and methods of producing those antigens
IT1158665B (it) Reagenti per la determinazione di prodotti immunologicamente attivi e metodo immunologici in cui si usano detti reagenti
DE3175955D1 (en) Process for the deternination of antigens or antibodies
ATE40049T1 (de) Verfahren zur herstellung von hepatitis-boberfl|chenantigenfreien gammaglobulinen und produkte.
DE3485733D1 (de) Spezifische antigene der cea(karzyno-embryonales-antigen)familie, spezifische antikoerper und verfahren zu ihrer verwendung.
IT1177799B (it) Apparecchio e metodo per la palettizzazione di pacchi di fogli
DE3787706D1 (de) Verfahren zur quantitativen Bestimmung der Antigene und Antikörper.
IL71953A (en) Malaria associated antigen,process for preparation thereof and vaccine comprising it
AT370647B (de) Verfahren zur ausbildung von rohrbogen und einrichtung zur durchfuehrung des verfahrens
DE3650139D1 (de) Verfahren zum reduzieren der immunogenizität und zum induzieren immunologischer toleranz.
ES526622A0 (es) Procedimiento de producir antigenos y sus intermedios
GB2114288B (en) Method for the detection of malaria antigens in human blood
AT365549B (de) Verfahren zur waermebehandlung von glas sowie fluidisiertes bett zur durchfuehrung des verfahrens
ATE80469T1 (de) Partikel sowie verfahren zum nachweis von antigenen und/oder antikoerpern unter verwendung der partikel.
ATA92082A (de) Verfahren zur begasung von fluessigkeiten, sowie eine begasungseinrichtung zur durchfuehrung des verfahrens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee